BCLC 2025 Guidelines introduce a new model to personalize liver cancer treatment
The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clínic1
The Barcelona Clínic Liver Cancer (BCLC) group, within the framework of the Clínic Barcelona Comprehensive Cancer Center —a center promoted by Clínic1
An international controlled clinical study published in The New England Journal of Medicine demonstrates that liquid biopsy can help identify which p1
The Clínic Barcelona Comprehensive Cancer Center (4CB), a center promoted by Clínic, IDIBAPS and the University of Barcelona, has presented a total o1
"La Caixa" Foundation will allocate €150,000 to the project led by Alba Rodríguez, from the IDIBAPS Cellular Immunotherapies for Cancer research grou1
A study led by the Clínic Barcelona Comprehensive Cancer Center —a center driven by Clínic-IDIBAPS and the University of Barcelona (UB)— demonstrates1
Researchers from Clínic-IDIBAPS, within the Clínic Barcelona Comprehensive Cancer Center, and the spin-off Gyala Therapeutics have coordinated a stud1
Researchers from Clínic-IDIBAPS, within the framework of the Clínic Barcelona Comprehensive Cancer Center, have led a study analyzing how genetic mut1
An international team led by the Clínic-IDIBAPS and the Institute of Cancer Research in London has developed an innovative new method based on DNA me1
The Clínic Barcelona Comprehensive Cancer Center (4CB), driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona, has announced1
Researchers from the Clínic Barcelona Comprehensive Cancer Center—driven by Hospital Clínic Barcelona, IDIBAPS, and the University of Barcelona—toget1